LFB Biomanufacturing
Coralie Bernon has a diverse background in research and industrial processes, with experience in companies such as LFB Biomanufacturing and UPS CNRS 3044/NanoMedSyn. With a Doctorate in Biology-Health from the University of Lille 1 Sciences and Technology, Coralie has held roles such as Chargée de Recherche and Responsable développement des procédés et pilote. Their research focus has been on glycobiology, specifically studying the influence of cytosolic mannosidase on N-glycoproteins biosynthesis and degradation mechanisms.
LFB Biomanufacturing
LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Alès site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing is subsidiary of the LFB Group.